| For: | Xie SS, Liu ZG. Levodopa and the dopamine receptor D1-Hippo/yes-associated protein axis: A novel therapeutic avenue for liver fibrosis. World J Gastroenterol 2025; 31(46): 113298 [PMID: 41479642 DOI: 10.3748/wjg.v31.i46.113298] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i46/113298.htm |
| Number | Citing Articles |
| 1 |
Dan-Yu Yin, Xiang-Yi Liu, Ang Li, Zhi-Gang Ren. From the brain to the liver: A pharmacokinetic dilemma and safety barriers in levodopa-based antifibrotic therapy. World Journal of Gastroenterology 2026; 32(42): 117873 doi: 10.3748/wjg.117873
|
| 2 |
Stanislav Kotlyarov, Anna Kotlyarova, Roberto Catanzaro, Francesco Marotta. Canonical and Non-Canonical Regulators of Lipid Metabolism in the Liver and the “Liver–Other Organs” Axes. International Journal of Molecular Sciences 2026; 27(19) doi: 10.3390/ijms27198614
|